Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
According to MarketsandMarkets, The report Next-generation Sequencing Services Market is projected to grow from USD 3.80 billion in 2025 and ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
CAGR is driven by advancements in epigenetics research, methylation analysis technologies, and the rising need for personalized medicine U.S. Nucleic Acid Methylation Market U.S. Nucleic Acid ...
THETFORD MINES, QC, Dec. 22, 2025 /CNW/ – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative ...
The ongoing Italian clinical and research FPG500 program is designed to tailor matched targeted therapies (MTTs) based on "biomarkers predictive of response identified by comprehensive genome profiling ...
News-Medical.Net on MSN
RNAConnect launches the UltraMarathonRT Direct RNA‑Seq Kit to advance nanopore-based native RNA sequencing
RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial availability of the UltraMarathonRT® Direct RNA‑Seq (uMRT DRS) Kit, a native‑RNA ...
Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback